GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » EV-to-FCF

CRYM (Cryomass Technologies) EV-to-FCF : -6.07 (As of Dec. 12, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cryomass Technologies's Enterprise Value is $6.91 Mil. Cryomass Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.14 Mil. Therefore, Cryomass Technologies's EV-to-FCF for today is -6.07.

The historical rank and industry rank for Cryomass Technologies's EV-to-FCF or its related term are showing as below:

CRYM' s EV-to-FCF Range Over the Past 10 Years
Min: -2367.95   Med: -29.55   Max: -0.89
Current: -6.55

During the past 13 years, the highest EV-to-FCF of Cryomass Technologies was -0.89. The lowest was -2367.95. And the median was -29.55.

CRYM's EV-to-FCF is ranked worse than
100% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs CRYM: -6.55

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), Cryomass Technologies's stock price is $0.016. Cryomass Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.035. Therefore, Cryomass Technologies's PE Ratio (TTM) for today is At Loss.


Cryomass Technologies EV-to-FCF Historical Data

The historical data trend for Cryomass Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies EV-to-FCF Chart

Cryomass Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.19 -5.18 -8.17 -7.26 -3.15

Cryomass Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.00 -3.15 -4.34 -6.92 -8.08

Competitive Comparison of Cryomass Technologies's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryomass Technologies's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's EV-to-FCF falls into.



Cryomass Technologies EV-to-FCF Calculation

Cryomass Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6.912/-1.138
=-6.07

Cryomass Technologies's current Enterprise Value is $6.91 Mil.
Cryomass Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryomass Technologies  (OTCPK:CRYM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cryomass Technologies's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.016/-0.035
=At Loss

Cryomass Technologies's share price for today is $0.016.
Cryomass Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.035.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cryomass Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryomass Technologies Business Description

Traded in Other Exchanges
N/A
Address
1001 Bannock Street, Suite 612, Denver, CO, USA, 80204
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect, and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.
Executives
Christian Noel director, officer: Chief Executive Officer 3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Philip Blair Mullin officer: Chief Financial Officer 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic officer: GC, Corp Secy, and Head of EA 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113